Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Expanded_access × Urinary Bladder Neoplasms × Clear all

Status

Available 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 17 Melanoma 16 Neoplasms 13 Recurrence 12 Prostatic Neoplasms 12 Leukemia, Myeloid, Acute 10 Carcinoma, Non-Small-Cell Lung 9 Lymphoma 8 Glioblastoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Breast Neoplasms 7 Sarcoma 5 Pancreatic Neoplasms 5 Neuroblastoma 5 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Leukemia 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Liver Neoplasms 4 Lambert-Eaton Myasthenic Syndrome 4 Hodgkin Disease 4 Glioma 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Gastrointestinal Stromal Tumors 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03801278 2021-12-13

FPA144

Five Prime Therapeutics, Inc.

No longer available

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡